ByrneWallace advise Brindley Healthcare on its acquisition of Kilminchy Lodge Nursing Home

ByrneWallace advised data analytics specialist Presidion on its acquisition by Version 1.

ByrneWallace advised Phibro Animal Health Corporation, a NASDAQ listed global diverse animal health and mineral nutrition company.

Oaklee Housing one of the largest Approved Housing Bodies (AHBs) in Ireland

ByrneWallace advised Irish-listed pharmaceutical company Amryt Pharma PLC on an exclusive in-licence agreement with University College Dublin.

ByrneWallace advised Mainstream Renewable Power Limited

ByrneWallace advised the shareholders of Hattrick Sports Group Limited on its sale to sports betting company Fortuna Entertainment Group N.V.

ByrneWallace advised Exeter Ireland Property III Limited, part of the Exeter Property Group.

ByrneWallace advised Brindley Healthcare.

Advised MML Growth Capital Partners Ireland on their investment in leading Irish guided tour operator.

ByrneWallace advised Castlethorn on their development Brighton Wood.

Acted for Browserstack Limited in relation to its $50 million Series Funding round with Accel.

ByrneWallace advised Rothco on its sale to Accenture.

ByrneWallace advised Renewables Infrastructure Group.

Advised PetroNeft Resources plc in connection with a facility advanced by Petrogrand AB.

ByrneWallace advised Zalando, Europe’s leading online fashion platform.

Advised Multihog Limited on its €7 million investment funding round.

ByrneWallace advised Castlethorn on the development of Grace Park Wood.

ByrneWallace advised Mainstream Renewable Power Limited.

ByrneWallace advised on the set up of the BioExel Partnership Programme.

Advised the shareholders of Hattrick Sports Group Limited on its sale to Fortuna Entertainment Group

ByrneWallace advised Ireland‘s largest magazine publisher, Harmonia.

ByrneWallace advised Elmhill Homes on all legal aspects of their residential development, The Paddocks.

ByrneWallace advised AIB in relation to the 20-year lease of its new corporate headquarters

ByrneWallace advised Newlyn Developments

Advised UBiqube (Ireland) Plc on its Series A round of funding from Fujitsu Limited, NTT Docomo Ventures and Fortinet, Inc.

Advised MML Growth Capital Partners Ireland in its investment in Fastway Couriers (Ireland)

Advised Renatus Capital and Martello Group on their acquisition of Simtech

ByrneWallace advised Newlyn Developments

ByrneWallace advised Elmhill Homes on all legal aspects of their residential development, Tivoli Place.

Advised Showtime Analytics on its fundraising with Alibaba Pictures subsidiary Yueke/Finixx

Advised Ocuco Limited on a €23 million financing from Wells Fargo’s Technology Finance unit and on its acquisition of B&F Group

Advisers to leading cyber security consultancy firm Integrity360

Advised Arconics on its sale to ViaSat

Advised founding investors in ElectroRoute as part of major new partnership with Mitsubishi Corporation.

Advised in the sale of a majority holding in Joule Group to Dutch buyer Inventum.

Acted for Inflazome Limited in connection with its recent Series A financing round for up to €15 million

Advised DMS on restructuring of QIAIF Unit Trust

Acted for Enterprise Equity (VC) in the exit of its investment in Movidius to Intel

Acted for Mainstream Renewable Power Limited in the $117.5 million investment in its Lekela Africa power platform.

Irish Law Counsel to Wilmington Trust

Advising Aminex plc on a proposed equity funding to raise up to Stg£19.5m (US$25.4m) by the issue of new shares

Acted for Hospital Services Limited in its acquisition of the assets of Endosurgical (NI) Limited.

Acted for Irish Life Assurance Plc in its purchase of prime retail unit no. 50 Grafton Street, Dublin

Advised United Language Group, Inc on the acquisition of Merrill Brink International

Advised Aztec Exchange on structured debt financing for global internet receivables purchase programme

Advised Jefferies LoanCore LLC as senior lender to Fibinacci QIAIF ICAV

Acted for Endeco Technologies Limited in raising €3.3 million from the ESB Novus Modus Fund.

Acted for Amryt Pharmaceuticals Designated Activity Company (Amryt DAC) on the reverse takeover of Fastnet Equity plc

Advised Exeter Property Group on the purchase and transfer of a commercial property portfolio

Advised BSI (British Standards Institution) on its acquisition of Espion Limited and its wholly owned subsidiary Espion (UK) Limited

Advised Codec-dss on its acquisition of CRM firm Vulcan.ie

Advised a cornerstone investor on a significant investment in up and coming Troy Studios

Advised on the establishment of long-only mid cap US equities fund as a UCITS fund

ByrneWallace advised Teamer on the strategic acquisition of Club Website Limited, a UK based online sports club service in a cash and share based deal.

Advised Clavis Insight on a US$20 million equity investment from private equity firm Accel-KKR and existing investors.

Advised Tricadia on the establishment of credit orientated hedge fund

Advised 3D4Medical on the sale of a 38% stake in the Company to Malin Corporation plc

Advised in the proposed acquisition of IFG Group Plc’s Irish insurance brokerage business ARB Underwriting Limited

Advised Callan Bacon in relation to the acquisition of UK based wholesale supplier Stirchley Bacon

Advised Renatus Capital Partners Ltd on to its acquisition of Boojum Ltd, Ireland’s largest Mexican restaurant chain

ByrneWallace advised dual listed oil and gas exploration and production company Aminex plc in relation to a €2.3m placing of new shares.

Advised Mutares AG on the sale of Suir Pharma Ireland to Saneca Pharmaceuticals

Advised Altan Pharma on its recent investment by Malin plc. and other international investors

Acted for Qualtrics in the lease of its headquarter offices at One Clarendon Row, Dublin 2

Adviser to Renatus Capital Partners on a registered AIF limited partnership.

Advised Zalando on the establishment of it Irish tech operations

Advised New York based investment firm Tricadia Capital Management in relation to the establishment of a senior debt fund focussed on commercial property lending in the Irish market.

Acted for Nexvet Biopharma plc in relation to its fully underwritten US$40m IPO

Advised Aminex PLC (LSE/ISE : AEX) in relation to the sale of part of its interest in the Kiliwani North Development Licence to Solo Oil PLC

Advised the shareholders of Nexala Limited in relation to the sale of the company to Trimble (NASDAQ: TRMB).

Acted for the shareholders of Techno-Path Distribution (“TPD”) in respect of their sale of 80% of TPD to publicly listed Diploma PLC (“Diploma”) and in relation to put and call agreements with regard to the remaining shareholding.

ByrneWallace advised Aminex PLC, dual listed on the Irish and London Stock Exchanges, on the disposal of its US subsidiary Aminex USA Inc. to Northcote Energy.

Acting as Irish legal advisor to publicly traded specialty pharmaceutical company.

Advised Royal Bank of Canada in relation to the financing

Acted as special internal counsel to Mainstay Medical International plc on its IPO on the Irish Enterprise.

Acted as Irish counsel for Heart Metabolics Limited on the completion of a $20 million Series A financing from venBio, Seroba Kernel Life Sciences, AustralianSuper and AshHill.

ByrneWallace advised iCON Infrastructure on its consortium bid for Bord Gais Energy from the Irish government, with enterprise value of c. €1.1 billion.

ByrneWallace advised Redline Capital Management in a significant equity investment into Irish high tech company Innalabs Ltd.

ByrneWallace acted for the special liquidators on the Project Evergreen loan sales.

ByrneWallace acted for a private Investor in the sale of Fleming Court, a multi-occupied office block on Mespil Road, Dublin 4 to Ardstone Capital Limited.

Advised Arbor Pharmaceuticals Ireland Limited on its licensing, development and commercialisation agreement with Takeda Pharmaceuticals for its hypertension products, EDARBI and EDARBYCHLOR.

ByrneWallace advised on the demerger of Erigal and M2i, both leading suppliers of radio-pharmaceutical tracers for assessing cancers.

ByrneWallace advised QualiMed Innovative Produkte GmbH and amg International GmbH on their reorganisation, including the incorporation of Q3 Medical Devices Ltd.

ByrneWallace advised Blackbaud Inc. (NASDAQ: BLKB) on its acquisition of MyCharity.ie.

ByrneWallace acted for Quality Healthcare on its sale of Shanakiel Hospital, Cork which is now relocated and operating as Mater Private at Mahon Point, Cork.

ByrneWallace acted for the Irish subsidiary of Amarin Corporation in Amarin’s $100m hybrid debt-like financing with Biopharma.

ByrneWallace acted for Swrve on its fundraising of $6.25 million (€4.92 million) led by Atlantic Bridge Partners and Intel Capital.

ByrneWallace acted for U.S Oil & Gas plc in obtaining a 'Norwich Pharmacal' Order from the High Court against two UK and one Irish websites.

ByrneWallace advised GenCell Biosystems on its €2.7 million seed fundraising and in relation to a number of commercial agreements.

Advised Averda Group on its €15m investment in Galway based waste management business, The City Bin Co, including acquisition of a majority shareholding & creation of 35 new jobs. Averda Group is a leading Middle-East based waste management business serv

Represented Mainstay Medical in its $20m Series B financing from Fountain, Sofinnova Partners, Medtronic, Capricorn, Seventure and other investors, and the relocation fromUSA to Ireland.

Acted for i360 medical, which aims to tap Ireland’s growing medical device expertise to generate and commercialise healthcare technology solutions and will replace the Centre for Innovation in Surgical Technology (CIST), based within the RCSI since 2008.

Advised the shareholders in the US€7m final payment of the Trade Sales of Stokes Bio to Life Technologies made through the Bank of Oreland Kernel Capital Private Equity Fund

Advised management on the management buy-out of the PH Ross, Commons Hardware, Wickes Limerick, and C & D Providers DIY businesses from Home Project Centre.

Advised Alimentary Health Ltd on the extension to its relationship with The Procter and Gamble Company. This agreement furthers joint research into next-generation probiotic organisms.

Acted for Welsh based Premier Forest in its acquisition of the business and assets of Brooks Timber from liquidator Kieran Wallace. The acquisition of included six outlets throughout Ireland.

Advised Imperative Energy on its recent fundraising and investment by the UK based North West Fund (NWF4EE) managed by Carbon Trust Investment Partners; and, investment by project finance specialist Environmental Infrastructure Development Company (EIDC).

Advised Azur Pharma on its merger with Nasdaq-listed Jazz Pharmaceuticals Inc.

Advised the Vendors in the sale of Firecrest Clinical to ICON plc.

Advised Broadlake Capital on the 100% acquisition of the UK based Aqua Filter.

Advised Nowcasting Group in its sale to Meteo Group, Europe’s leading private weather forecasting company.

Advised Apica Cardiovascular on the investment by Seroba Kernel Life Sciences and Triventures, and the licensing of technology from Georgia Tech and Emory University.

Advised brite:bill on its recent equity fundraising with the Ulster Bank Diageo Venture Fund.

Advised Norwegian technology company Visma AS on the acquisition of DBS Business Solutions International Limited.

Advised the Examiner in the successful restructuring of Comhfhorbairt (Gaillimh) trading as Aer Arann, Ireland’s only regional airline and the second largest regional airline in Ireland and the British isles.

Advised Dalco Nitrogen systems on the provision of their new nitrogen gas generating system

Acted for GetItKeepit.com in its recent equity capital fundraising, to fund its expansion into Britain and to commercialise its technology as a separate service.

Advised the shareholders of Stokes Bio on the sale of their shareholdings in Stokes Bio Limited as part of a trade sale of the firm to NASDAQ quoted Life Technologies (total sale consideration US$44m).

Advising OpenHydro Group Limited in relation to c.€15m private equity financing.

Advised Avoca Capital Holdings in relation to its appointment as replacement investment manager for the €400m ACA Euro CLO 2007-1 plc fund.

Advised Azur on the acquisition of the worldwide rights (other than Europe) to Prialt ® from Elan Pharmaceuticals Inc. which is used for the management of chronic pain in the USA. will offer employment to a 34 person specialty pharmaceutical infrastructur

Advised the Shionogi Pharmaceuticals Group on a major international licensing agreement with QuatRx, a private pharmaceutical company.

Advisers to First Derivatives plc in connection with the acquisition of the business and assets of Cognotec Holdings Limited (In Receivership).

Advisers to Iontas Limited on c.US$15m sale to Verint Systems Inc. (US).

Advised Atamia on the launch of its new tournament service on their website faceoffgames.com which allows players to gamble on head-to-head matches on their game consoles.

Adviser to C&F Wind Energy Limited, part of the Galway-based C&F Tooling Group. C&F Wind Energy is a new entrant to the green energy market and is the first to 100% design and manufacture their patented wind turbine technology in Ireland.

Advised software and outsourcing consultancy firm, Percana Group, on their 11 year business process outsourcing contract with top 10 UK life assurer, the Pearl Group, which encompasses Scottish Mutual International Limited and Phoenix Ireland (previously

Advised Stokes Bio Limited on a major international licensing and R&D collaboration agreement with Monsanto, a global agricultural and biotechnology company.

Acted for Green Diamond Technologies, a provider of green software solutions to the environmental industry, in their successful BES fundraising.

Advised the appointed contractor StructureTone Limited, in relation to the design and build contract it entered into with Interxion Ireland Limited for its €12million 2,455sq m data centre in Parkwest Industrial Centre, Dublin. Also advised StructureTone

Advised Avoca Capital Holdings on its appointment as replacement investment manager for CLIO European CLO B.V. replacing Lehman Brothers International (Europe).

Advised Chartered Land on letting to Marks & Spencer as anchor tenant for the Pavilions Phase 3. On completion this will be the largest M&S store in Ireland contained within what is expected to become the largest shopping centre in Ireland at over 1 milli

Advised payment security systems provider Sysnet in recent investment by US investor GTX Partners LLC.

Advised the C&F Group on its acquisition of the assets of German automotive components company J.P.B. Prometall GmbH.

Advised the shareholders of Techstaff Recruitment in the sale of its assets to the CPL Group.

Advised the management team on its MBO of Sigmar Recruitment Consultants Limited.

ByrneWallace advised Avoca Capital in relation to Absalon Credit Fund, a €100 million transaction.

Advised Imperative Energy Limited, an Irish based supplier of bioenergy solutions to clients in the UK and Ireland, on fundraising of up to €30m through entities associated with Englefield Capital.

Advised Avoca Capital Holdings in relation to its appointment as replacement investment manager for the €840m CLIO European CLO B.V., replacing Lehman Brothers International (Europe).

Advised the Ultralase Group (a leading U.K healthcare company specialising in vision correction) in the successful acquisition out of examinership of SMW Laser Limited and KPW Laser Limited (both trading as Eye Laser Ireland).

ByrneWallace advised Avoca Capital in relation to Avoca CLO IX Fund, a €325 million Collaterised Loan Obligation (CLO) transaction.

Advised OpenHydro Group on Tidal Site Development Agreement with Electricite de France, June 2009.

Advised Dublin-based data quality software company Clavis Technology on its €2.1 million funding round, led by Delta Partners and Scottish Equity Partners.

Advised US pharmaceutical company Sciele Pharma Inc on Irish aspects of its acquisition by the leading Japanese pharmaceutical company Shionogi & Co and its subsequent group restructuring.

Advised Azur on its acquisition of the US rights to Elestrin for US$3.3m.

ByrneWallace advised Elan on the sub-license to AstraZeneca to develop and commercialise Unit Dose Budesonide.

Negotiated the acquisition and funding of Flannerys Pub, one of Ireland’s best known and most successful public houses, and adjoining properties with excellent development potential on Lower Camden Street, Dublin 2.

ByrneWallace advised OpenHydro Group on their investment in Alderney Renewable Energy Limited.

ByrneWallace advised Azur on their agreement with Elan to develop and commercialise once-daily formulations of clozapine using Elan’s proprietary technologies.

Advised Merrion on their license agreement with Novo Nordisk to develop and commercialise oral formulations of Novo Nordisk’s proprietary Insulin analogues, using Merrion’s proprietary GIPET® technology.

ByrneWallace advised OpenHydro Group on Turbine Development Project with Nova Scotia Power.

ByrneWallace advised C&F Tooling on the acquisition of the assets of the Irish automotive tooling company, Iralco including transfer of over 300 employees.

On-going advice on what will be Ireland’s largest ever urban development project consisting of retail, commercial and residential units. Deal value €2bn.

Negotiated on behalf of Tommy Hilfiger Europe the acquisition of a leasehold interest on Grafton Street, Dublin 2. Comprising over 10,500 sq. ft. and a reported rent of €1.68M rent annually, this will be Tommy's flagship store in Ireland.

Advised US based Hemcon Medical Technologies, Inc. on its acquisition of Alltracel Pharmaceuticals plc by court sanctioned scheme of arrangement.

Advised on the sale of Limerick based Vigitek to US acquirer Quad/Tech, Inc.

Advised on this large-scale mixed use development off Grafton Street. Work included the letting of the retail units to leading retailers, Zara, H&M and Warehouse and the forward sale of a 90% interest in these units to Anglo Irish Assurance Company.

Advised Warren Private Clients on the successful negotiation of contracts relating to the acquisition of Phase 2, The Park Carrickmines.

Advised on the Phase 2 extension to the Pavilions Shopping Centre, Swords, which included project finance, construction, letting and general advisory.

Advising on the acquisition, development, letting and forward sale of this 120,000 square feet shopping centre which is anchored by the largest Dunnes Stores in the South East.

On-going advice to Castlethorn Construction, developers of the Adamstown SDZ on the planning, construction, sale and letting of a new town in west Dublin with 10,000 residential units and a number of distinct commercial units.

Legal advisers to Elan in the licensing of NanoCrystal® Technology to EntreMed Inc. for Panzem® cancer drug.

Legal advisers to Anglo Irish Bank in providing construction finance for Airtricity’s Braes of Doune Scottish Wind farm.

Legal Advisers to Alimentary Health Limited on the conclusion of a worldwide licence agreement with The Procter & Gamble Company. Alimentary Health licensed its proprietary probiotic technology to P&G for gastrointestinal indications.

Legal advisers to Howard Holdings in structuring the acquisition of the leasehold interest in the Whitgift Centre, Croydon, England.

Legal advisers to the vendors in the sale of Sita Environmental.

Advised on all aspects of this substantial urban mixed use redevelopment project (which incorporates Ireland's largest shopping centre) including planning, land acquisition, commercial lease negotiation and construction. Deal value of €1bn.

Legal advisers to Bank of Scotland (Ireland) in relation to the acquisition of W & R Jacobs By Fruitfield Foods